IBD (Inspire Corporate Bond ETF) Stock Analysis

Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest IBD stock research?

Inspire Corporate Bond ETF (IBD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBD moved +0.00% today.

IBD Key Metrics

Key financial metrics for IBD
MetricValue
Price$23.80
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume139.86K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBD News

IBD Analyst Consensus

IBD analyst coverage data. Average price target: $0.00.

Common questions about IBD

What can I research for IBD on Rallies?
Inspire Corporate Bond ETF (IBD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBD moved +0.00% today.
Does Rallies show live market data for IBD?
Rallies combines live market context with ticker research for IBD, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
IBD

IBD